Literature DB >> 19943243

Suppression of inducible nitric oxide synthase expression by furfuran lignans from flower buds of Magnolia fargesii in BV-2 microglial cells.

Ji Sun Kim1, Jae Yeon Kim, Hwa Jin Lee, Hyo Jin Lim, Da Yeon Lee, Do Hee Kim, Jae-Ha Ryu.   

Abstract

Activated microglia produces diverse neurotoxic factors such as nitric oxide (NO) and tumor necrosis factor-alpha that serve as apoptotic inducers resulting in various neurodegenerative diseases. The inhibition of microglia-derived NO production by inducible nitric oxide synthase (iNOS) has been reported to be beneficial in retarding neurodegenerative disorders. Three active lignans have been isolated from the flower buds of Magnolia fargesii by the bioassay-guided fractionation using lipopolysaccharide (LPS)-activated BV-2 microglial cell culture system. The structures of them were identified as kobusin (1), aschantin (2) and fargesin (3) by the analyses of spectroscopic data. They inhibited the production of NO by activated microglia. Their IC(50) values were 21.8 +/- 3.7, 14.8 +/- 2.5 and 10.4 +/- 2.8 microg/mL, respectively. They suppressed LPS-induced NF-kappaB activation and the expression of iNOS protein and mRNA. Furthermore, they showed scavenging activity of neurotoxic peroxynitrite that can be produced by NO and superoxide anion. These results imply that lignans from Magnolia fargesii might be beneficial for the treatment of neuro-inflammatory diseases through the inhibition of iNOS expression and peroxynitrite scavenging potential. Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19943243     DOI: 10.1002/ptr.3028

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

1.  Attenuated glutamate induced ROS production by antioxidative compounds in neural cell lines.

Authors:  Haolin Xin; Ying Cui; Zhongping An; Qian Yang; Xuan Zou; Ning Yu
Journal:  RSC Adv       Date:  2019-10-28       Impact factor: 4.036

2.  Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts.

Authors:  Ah Young Jun; Hyun-Jeong Kim; Kwang-Kyun Park; Kun Ho Son; Dong Hwa Lee; Mi-Hee Woo; Won-Yoon Chung
Journal:  Invest New Drugs       Date:  2013-05-15       Impact factor: 3.850

3.  Fargesin, a component of Flos Magnoliae, stimulates glucose uptake in L6 myotubes.

Authors:  Sun-Sil Choi; Byung-Yoon Cha; Bong-Keun Choi; Young-Sil Lee; Takayuki Yonezawa; Toshiaki Teruya; Kazuo Nagai; Je-Tae Woo
Journal:  J Nat Med       Date:  2012-07-12       Impact factor: 2.343

Review 4.  Effects of naringin, a flavanone glycoside in grapefruits and citrus fruits, on the nigrostriatal dopaminergic projection in the adult brain.

Authors:  Un Ju Jung; Sang Ryong Kim
Journal:  Neural Regen Res       Date:  2014-08-15       Impact factor: 5.135

5.  Magnolin protects against contrast-induced nephropathy in rats via antioxidation and antiapoptosis.

Authors:  Feng Wang; Guangyuan Zhang; Yang Zhou; Dingkun Gui; Junhui Li; Tao Xing; Niansong Wang
Journal:  Oxid Med Cell Longev       Date:  2014-10-21       Impact factor: 6.543

6.  Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.

Authors:  Ju-Hyun Kim; Soon-Sang Kwon; Hyeon-Uk Jeong; Hye Suk Lee
Journal:  Int J Mol Sci       Date:  2017-05-01       Impact factor: 5.923

7.  Fargesin Inhibits EGF-Induced Cell Transformation and Colon Cancer Cell Growth by Suppression of CDK2/Cyclin E Signaling Pathway.

Authors:  Ga-Eun Lee; Cheol-Jung Lee; Hyun-Jung An; Han Chang Kang; Hye Suk Lee; Joo Young Lee; Sei-Ryang Oh; Sung-Jun Cho; Dae Joon Kim; Yong-Yeon Cho
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

8.  Tetrahydrofurofuranoid Lignans, Eudesmin, Fargesin, Epimagnolin A, Magnolin, and Yangambin Inhibit UDP-Glucuronosyltransferase 1A1 and 1A3 Activities in Human Liver Microsomes.

Authors:  Ria Park; Eun Jeong Park; Yong-Yeon Cho; Joo Young Lee; Han Chang Kang; Im-Sook Song; Hye Suk Lee
Journal:  Pharmaceutics       Date:  2021-02-01       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.